Free Trial

10x Genomics (TXG) News Today

10x Genomics logo
$8.61 +0.18 (+2.14%)
Closing price 04:00 PM Eastern
Extended Trading
$8.60 0.00 (-0.06%)
As of 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
10x Genomics, Inc. stock logo
Tudor Investment Corp ET AL Sells 109,061 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
Tudor Investment Corp ET AL cut its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 35.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 200,011 shares of the company's stock after selling 109,061 shares durin
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Marshall Wace LLP
Marshall Wace LLP trimmed its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 90.0% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 46,861 shares of the company's stock after selling 420,262 shares during the period. Marsha
10x Genomics, Inc. stock logo
RA Capital Management L.P. Purchases Shares of 3,279,401 10x Genomics, Inc. (NASDAQ:TXG)
RA Capital Management L.P. bought a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 3,279,401 shares of the company's stock, valued at approximately $
10x Genomics, Inc. stock logo
Susquehanna Fundamental Investments LLC Takes Position in 10x Genomics, Inc. (NASDAQ:TXG)
Susquehanna Fundamental Investments LLC acquired a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 106,788 shares of the company's stock, valued at approxim
10x Genomics, Inc. stock logo
Price T Rowe Associates Inc. MD Sells 734,635 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
Price T Rowe Associates Inc. MD decreased its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 29.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,781,268 shares of the company's stock after selling 734,635 share
10x Genomics, Inc. stock logo
10x Genomics (TXG) Expected to Announce Quarterly Earnings on Thursday
10x Genomics (NASDAQ:TXG) will be releasing its Q1 2025 earnings after the market closes on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-10x-genomics-inc-stock/)
10x Genomics, Inc. stock logo
PDT Partners LLC Acquires 226,513 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
PDT Partners LLC raised its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 176.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 354,958 shares of the company's stock after acquiring an
10x Genomics, Inc. stock logo
Aquatic Capital Management LLC Makes New Investment in 10x Genomics, Inc. (NASDAQ:TXG)
Aquatic Capital Management LLC purchased a new position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 129,029 shares of the company's stock, valued at approximately
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Shares Gap Up - Time to Buy?
10x Genomics (NASDAQ:TXG) Shares Gap Up - What's Next?
10x Genomics, Inc. stock logo
Three Seasons Wealth LLC Makes New $444,000 Investment in 10x Genomics, Inc. (NASDAQ:TXG)
Three Seasons Wealth LLC purchased a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 30,948 shares of the company's stock, valued at approximately $44
10x Genomics, Inc. stock logo
10x Genomics' (TXG) Sell (E+) Rating Reiterated at Weiss Ratings
Weiss Ratings reaffirmed a "sell (e+)" rating on shares of 10x Genomics in a research note on Thursday.
10x Genomics, Inc. stock logo
86,504 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Purchased by Dark Forest Capital Management LP
Dark Forest Capital Management LP acquired a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 86,504 shares of the company's stock, value
10x Genomics, Inc. stock logo
Canada Pension Plan Investment Board Buys 42,700 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
Canada Pension Plan Investment Board boosted its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 27.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 200,200 shares o
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Stock Holdings Boosted by Barclays PLC
Barclays PLC lifted its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 31.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 790,957 shares of the company's stock after buying an additional 188,421 shares during the pe
10x Genomics, Inc. stock logo
Renaissance Technologies LLC Acquires Shares of 386,955 10x Genomics, Inc. (NASDAQ:TXG)
Renaissance Technologies LLC bought a new position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 386,955 shares of the company's sto
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. cut its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 16.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 296,902 shares of the company's stock after selling 58,586 shares
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Shares Gap Down - Here's Why
10x Genomics (NASDAQ:TXG) Shares Gap Down - What's Next?
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Holdings Boosted by Capital Fund Management S.A.
Capital Fund Management S.A. raised its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 36.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 304,832 shares of the company's sto
10x Genomics, Inc. stock logo
Fmr LLC Raises Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
Fmr LLC increased its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 0.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,454,434 shares of the company's stock after buying an add
10x Genomics price target lowered to $12 from $16 at BofA
10x Genomics, Inc. stock logo
Norges Bank Acquires New Position in 10x Genomics, Inc. (NASDAQ:TXG)
Norges Bank bought a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 91,579 shares of the company's stock, valued at approximately
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Receives Consensus Rating of "Hold" from Analysts
10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) has been given an average recommendation of "Hold" by the seventeen research firms that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, nine have issued a hold ratin
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Shares Up 7% - Here's What Happened
10x Genomics (NASDAQ:TXG) Shares Up 7% - Time to Buy?
10x Genomics, Inc. stock logo
National Bank of Canada FI Purchases New Position in 10x Genomics, Inc. (NASDAQ:TXG)
National Bank of Canada FI acquired a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 105,700 shares of the company's stock, valued at approx
Barclays Reaffirms Their Buy Rating on 10x Genomics (TXG)
10x Genomics price target lowered to $12 from $15 at Barclays
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Receives Sell (E+) Rating from Weiss Ratings
Weiss Ratings reaffirmed a "sell (e+)" rating on shares of 10x Genomics in a research report on Tuesday.
10x Genomics, Inc. stock logo
ExodusPoint Capital Management LP Sells 366,528 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
ExodusPoint Capital Management LP cut its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 66.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 188,430 shares of the c
10x Genomics, Inc. stock logo
Vanguard Group Inc. Has $157.01 Million Stake in 10x Genomics, Inc. (NASDAQ:TXG)
Vanguard Group Inc. cut its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,933,549 shares of the company's stock after selling 39,381 shares du
10x Genomics, Inc. stock logo
Cinctive Capital Management LP Sells 138,106 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
Cinctive Capital Management LP trimmed its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 84.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,479 shares of the company's stock after selling
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Shares Bought by Trexquant Investment LP
Trexquant Investment LP raised its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 196.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 594,611 shares of the company's stock after purchasi
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Sets New 12-Month Low - What's Next?
10x Genomics (NASDAQ:TXG) Hits New 52-Week Low - Should You Sell?
10x Genomics, Inc. stock logo
IQ EQ FUND MANAGEMENT IRELAND Ltd Increases Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
IQ EQ FUND MANAGEMENT IRELAND Ltd boosted its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 160.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 52,787 shares of the company's stock after purchasing an addition
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Stock Price Down 5.7% - Time to Sell?
10x Genomics (NASDAQ:TXG) Shares Down 5.7% - Here's Why
10x Genomics, Inc. stock logo
Quantbot Technologies LP Invests $1.03 Million in 10x Genomics, Inc. (NASDAQ:TXG)
Quantbot Technologies LP acquired a new position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 71,429 shares of the company's stock, valued at appro
10x Genomics, Inc. stock logo
Charles Schwab Investment Management Inc. Trims Position in 10x Genomics, Inc. (NASDAQ:TXG)
Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 17.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 539,666 shares of the company's stock after selling 11
10x Genomics, Inc. stock logo
Amundi Reduces Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
Amundi reduced its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 98.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,988 shares of the company's stock after selling 98,904 shares
10x Genomics, Inc. stock logo
Primecap Management Co. CA Lowers Stock Position in 10x Genomics, Inc. (NASDAQ:TXG)
Primecap Management Co. CA trimmed its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 56.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 127,600 shares of the company's stock
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Short Interest Up 21.6% in February
10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) was the target of a significant increase in short interest in February. As of February 28th, there was short interest totalling 13,770,000 shares, an increase of 21.6% from the February 13th total of 11,320,000 shares. Currently, 12.6% of the shares of the company are sold short. Based on an average trading volume of 2,480,000 shares, the short-interest ratio is presently 5.6 days.
10x Genomics, Inc. stock logo
Bank of New York Mellon Corp Reduces Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
Bank of New York Mellon Corp lessened its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 13.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 290,031 shares of the company's stock after selling 45,337 shar
10x Genomics, Inc. stock logo
Nikko Asset Management Americas Inc. Reduces Stock Position in 10x Genomics, Inc. (NASDAQ:TXG)
Nikko Asset Management Americas Inc. lessened its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 10.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,713,484 shares of the company's stock after sellin
10x Genomics, Inc. stock logo
Counterpoint Mutual Funds LLC Invests $742,000 in 10x Genomics, Inc. (NASDAQ:TXG)
Counterpoint Mutual Funds LLC acquired a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 51,658 shares of the company's stock, valued at approximately $742,
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Receives Average Rating of "Hold" from Analysts
10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) has been assigned an average rating of "Hold" from the seventeen brokerages that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and seve
Get 10x Genomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter.

TXG Media Mentions By Week

TXG Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TXG
News Sentiment

1.07

0.72

Average
Medical
News Sentiment

TXG News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TXG Articles
This Week

11

6

TXG Articles
Average Week

Get 10x Genomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TXG) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners